Clinical decision support systems (CDSS) are computer-based programs that analyze data within EHRs to provide prompts and reminders to assist health care providers in implementing evidence-based clinical guidelines at the point of care. Garnering a CAGR of 8.9% from 2022 to 2028, the clinical decision support system market in United States is projected to reach worth of USD 7,244 million by 2028-end, according to a new report by Gen Consulting Company.

This industry report offers market estimates of the United States market, followed by a detailed analysis of the product type, mode of advice, model, application, and end user. The United States market data on clinical decision support system can be segmented by product type: integrated, standalone. Clinical decision support system market is further segmented by mode of advice: passive, active. Based on model, the clinical decision support system market is segmented into: knowledge-based, non-knowledge based. On the basis of application, the clinical decision support system market also can be divided into: decision delivery, decision workflow, decision analytics, decision evidence. The decision delivery segment is estimated to account for the largest share of the clinical decision support system market in United States. Clinical decision support system market by end user is categorized into: hospitals and clinics, ASCs, others.

The United States clinical decision support system market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Allscripts Healthcare Solutions Inc., athenahealth Inc., Change Healthcare Inc., EBSCO Industries Inc., eClinicalWorks LLC, Elsevier Plc (RELX Plc), Epic Systems Corporation, Flatiron Health Inc., HCA Healthcare Inc., Hearst Communications Inc., International Business Machines Corporation, Koninklijke Philips N.V., Oracle Corporation, Symphony Performance Health Inc., Wolters Kluwer N.V.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.


Why buy this report?

  • Get a detailed picture of the United States Clinical Decision Support System Market
  • Identify segments/areas to invest in over the forecast period in the United States Clinical Decision Support System Market
  • Understand the competitive environment, the market’s leading players
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.